ASSOCIATION OF SCD40 LEVEL IN SERUM WITH RISK FOR RELAPSE IN GRAVES DISEASE

UPT. PERPUSTAKAAN Universitas Esa Unggul Kampus Emas UEU - Jakarta Barat
Phone	:	021-5674223, ext 282
Fax	:
E-mail	:	[email protected]
Website	:	http://library.esaunggul.ac.id
Support (Customer Service) :
[email protected]

Welcome..guys!

Have a problem with your access?
Please, contact our technical support below:

LIVE SUPPORT

Astrid Chrisafi

! ATTENTION !

To facilitate the activation process, please fill out the member application form correctly and completely

Registration activation of our members will process up to max 24 hours (confirm by email). Please wait patiently

Still Confuse?
Please read our User Guide

UEU » Scientific Articles » Fisioterapi
Posted by [email protected] at 21/08/2020 14:20:28 • 573 Views

ASSOCIATION OF SCD40 LEVEL IN SERUM WITH RISK FOR RELAPSE IN GRAVES DISEASE

Created by :
TRISIA LUSIANA AMIR, S.Pd,M.Biomed ( 217030664 )
DWI ANITA SURYANDARI FATIMAH ELIANA

Subject:	KESEHATAN
Alt. Subject :	HEALTH
Keyword:	GRAVES DISEASE RELAPSE REMISSION ELISA

Description:

CD40 is a transmembrane protein that influences the pathological of autoimmune disease, like Graves� Disease (GD). Interaction with its ligand (CD40L) on the surface of CD4 + and Dwi Yanti T cells can enhance the humoral immune response. Some studies indicated that GD patients have lower apoptosis in follicular cell. This condition related to sCD40 level, which also can increase autoantibodies in GD patients. The aim of this research was to find out the role of sCD40 as a marker on GD activity. This research was a case-control study comparing 30 relapse patients and 30 non-relapse patients (remission) after treatment with an antithyroid drug was terminated. The subject of this research was serum from both relapse and remission patients, analyzed by ELISA method. Statistical analyzes was independent t-test, a two-tailed p-value less than 0.05 was considered significant. The results, we found that sCD40 levels in serum (pg/ml) increased on relapse patients (1.62� 0.17) compared to remission patients (1.46�0.14) and showed that sCD40 level in serum was significantly different between relapse and remission (p<0.001). These results demonstrated that elevated levels of sCD40 serum, associated with risk for relapse. So, sCD40 may be used as a marker of the active stage of GD.

Date Create	:	21/08/2020
Type	:	Text
Format	:	PDF
Language	:	Indonesian
Identifier	:	UEU-Article-5_0297
Collection ID	:	5_0297

Source :
In Proceedings of the 1st International Conference on Health (ICOH 2019), pages 224-227

Relation Collection:
Fakultas Fisioterapi

Coverage :
Civitas Akademika Universitas Esa Unggul

Rights :
@2020 Perpustakaan Universitas Esa Unggul

Publication URL :
https://digilib.esaunggul.ac.id/association-of-scd40-level-in-serum-with-risk-for-relapse-in-graves-disease-15911.html

[ Free Download - Free for All ]